Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

5.0%

1 terminated/withdrawn out of 20 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
5(50.0%)
Phase 2
3(30.0%)
Phase 4
1(10.0%)
Phase 3
1(10.0%)
10Total
N/A(5)
Phase 2(3)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT04694079Phase 4Completed

Ventricular Tachycardia Ablation and Myocardial Scar Characterization With Magnetic Resonance

Role: collaborator

NCT06884631Recruiting

Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure

Role: collaborator

NCT06520137Recruiting

Third Molars Extraction and Periodontal Disease

Role: lead

NCT06472063Recruiting

Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study

Role: collaborator

NCT06192524Unknown

OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF Registry

Role: collaborator

NCT05956132Unknown

Clinical and Biochemical Features for the Identification of Dominant Calpainopathies

Role: collaborator

NCT05701293Recruiting

A ProspeCtive mUlticenteR Investigation on RENzar Stent Safety and Efficacy in the Treatment of Patients With Femoro-popliteal Disease in Tuscany (CURRENT Registry)

Role: lead

NCT05420805Not ApplicableCompleted

Protective Role of Pre-/ Post-biotics on Gut Inflammation, Dysbiosis, and Life Quality in Rett Syndrome (Biotics_RTT)

Role: lead

NCT05801497Unknown

Balneotherapy in Primary Fibromyalgia

Role: collaborator

NCT04361903Unknown

Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection

Role: collaborator

NCT04155554Phase 3Unknown

Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based Regimen

Role: lead

NCT03992170Phase 2Unknown

Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive

Role: lead

NCT03067909Completed

Antithrombotic Therapy in Patients Undergoing CIED Surgery - HEMATOMA NO MORE Registry

Role: lead

NCT03498664Not ApplicableUnknown

EMR-C VS EMR-S in Colonic Lateral Spreading Tumors Treatment (LST)

Role: lead

NCT03386370Not ApplicableUnknown

The Indigo System in Acute Lower Limb Malperfusion

Role: lead

NCT02548065Not ApplicableCompleted

Efficacy and Tolerability of Balneotherapy With Mineral Water Named" Debole of Vetriolo" in Fibromyalgia Syndrome

Role: lead

NCT02596646Not ApplicableTerminated

Early Precut in Difficult Biliary Cannulation

Role: collaborator

NCT01678950Completed

MostCare Versus Echo-Doppler for Cardiac Output Measurement

Role: lead

NCT01655888Phase 2Unknown

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Role: lead

NCT01649024Phase 2Unknown

A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

Role: lead

All 20 trials loaded